Acquisition / mergerNotableFiled on BSE ·

Anupam Rasayan India Limited announces open offer to acquire 26% of Bliss GVS Pharma

Bliss GVS Pharma

Arthneeti Research DeskPublished 1 min read
26%Acquisition / merger

Key highlights

  • Open offer to acquire up to 2,77,26,848 equity shares, 26.00% of Bliss GVS Pharma's Expanded Voting Share Capital
  • Offer price ₹299.00 per share; total consideration up to ₹8,29,03,27,552 assuming full acceptance
  • SPA dated 23 May 2026 with promoter and non-promoter sellers to acquire 4,58,03,024 shares (43.30% of equity share capital), subject to conditions precedent; completion follows the offer closure

Why it's rated notable: amount is ₹500 crore or more

Figures checked against the filing by a second AI read, which corrected the first summary. About the business, not the share price.

Original filing

Detailed Public Statement In Relation To Open Offer Made To The Public Shareholders Of The Company

Read the filing on BSE (PDF) →

Companies guiding to strong growth

Ranked by management's own guidance on revenue and margins — not by us.

Rossell Techsys

Aerospace & Defense

Revenue growth 40%+Margin up 2%+

Sign up free to see all 6 →

See full rankings

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

More from Bliss GVS Pharma

Other acquisition / merger filings this fortnight

All acquisition / merger filings →

Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.